Department of Sarcoma, Moffitt Cancer Center, CSB 6th Floor, 12902 USF Magnolia Drive, Tampa, FL, 33612, USA.
Department of Orthopaedic Surgery, Duke University Medical Center, Durham, NC, USA.
BMC Cancer. 2023 Jun 23;23(1):579. doi: 10.1186/s12885-023-11022-x.
Cartilaginous neoplasms can be challenging to grade; there is a need to create an evidence-based rubric for grading. The goal of this study was to identify histopathologic features of chondrosarcoma that were associated with 5-year survival and to compare these to traditional patient, tumor and treatment variables.
This was a retrospective review of all patients undergoing surgical resection of a primary chondrosarcoma with at least 2 years of follow up. All specimens were independently reviewed by two pathologists and histopathologic features scored. Univariate and multivariate analyses were performed utilizing Kaplan Meier and proportional hazards methods to identify variables associated with 5-year disease specific survival (DSS) and disease free survival (DFS).
We identified 51 patients with an average follow up of 49 months eligible for inclusion. 30% of tumors were low grade, 45% were intermediate grade, and 25% were high grade. In a univariate analysis considering histopathologic factors, higher tumor mitotic rate (HR 8.9, p < 0.001), tumor dedifferentiation (HR 7.3, p < 0.001), increased tumor cellularity (HR 5.8, p = 0.001), increased tumor atypia (HR 5.8, p = 0.001), LVI (HR 4.7, p = 0.04) and higher tumor necrosis (HR 3.7, p = 0.02) were all associated with worse 5-year DSS. In a multivariate analysis controlling for potentially confounding variables, higher tumor necrosis was significantly associated with disease specific survival survival (HR 3.58, p = 0.035); none of the factors were associated with DFS.
This study provides an evidence-based means for considering histopathologic markers and their association with prognosis in chondrosarcoma. Our findings suggest that necrosis and LVI warrant further study.
软骨肿瘤的分级具有挑战性;因此,需要建立一个基于证据的分级准则。本研究的目的是确定与 5 年生存率相关的软骨肉瘤的组织病理学特征,并将这些特征与传统的患者、肿瘤和治疗变量进行比较。
这是一项对所有接受至少 2 年随访的原发性软骨肉瘤手术切除患者的回顾性研究。所有标本均由两名病理学家独立进行复查,并对组织病理学特征进行评分。利用 Kaplan-Meier 和比例风险方法进行单变量和多变量分析,以确定与 5 年疾病特异性生存率(DSS)和无病生存率(DFS)相关的变量。
我们确定了 51 名符合纳入标准的患者,平均随访时间为 49 个月。30%的肿瘤为低级别,45%为中级,25%为高级。在考虑组织病理学因素的单变量分析中,较高的肿瘤有丝分裂率(HR 8.9,p<0.001)、肿瘤去分化(HR 7.3,p<0.001)、肿瘤细胞增多(HR 5.8,p=0.001)、肿瘤异型性增加(HR 5.8,p=0.001)、脉管内侵犯(HR 4.7,p=0.04)和肿瘤坏死增加(HR 3.7,p=0.02)均与 5 年 DSS 较差相关。在多变量分析中,控制潜在混杂变量后,肿瘤坏死与疾病特异性生存率显著相关(HR 3.58,p=0.035);没有一个因素与 DFS 相关。
本研究为软骨肉瘤中考虑组织病理学标志物及其与预后的关系提供了一种基于证据的方法。我们的发现表明,坏死和脉管内侵犯值得进一步研究。